Abstract
Background
The human microbiome plays a vital role in human health, mediated by the gut–brain axis, with a large diversity of functions and physiological benefits. The dynamics and mechanisms of meditations on oral and gut microbiome modulations are not well understood. This study investigates the short-term modulations of the gut and oral microbiome during an Arhatic Yoga meditation retreat as well as on the role of microbiome in improving well-being through a possible gut-brain axis.
Methods
A single-arm pilot clinical trial was conducted in a controlled environment during a 9-day intensive retreat of Arhatic Yoga meditation practices with vegetarian diet. Oral and fecal samples of 24 practitioners were collected at the start (Day0: T1), middle (Day3: T2), and end (Day9:T3) of the retreat. Targeted 16S rRNA gene amplicon sequencing was performed for both oral and gut samples. Functional pathway predictions was identified using phylogenetic investigation of communities by reconstruction of unobserved states (PICRUSt2). DESeq2 was used to identify the differential abundant taxa. Various statistical analyses were performed to assess the significant changes in the data.
Results
Our findings revealed that Arhatic Yoga meditation together with a vegetarian diet led to changes in the oral and gut microbiome profiles within the 9-day retreat. Oral microbiome profile showed a significant (p < 0.05) difference in the species richness and evenness at the end of study, while non-metric multidimensional scaling (NMDS) confirmed the shift in the gut microbiome profile of the practitioners by T2 timepoint, which was further supported by PERMANOVA analysis (p < 0.05). Health-benefiting microbes known to improve the gastrointestinal and gut-barrier functions, immune modulation, and gut-brain axis were enriched. Gut microbiome of both beginner and advanced Arhatic Yoga practitioners showed similar trends of convergence by the end of study. This implies a strong selection pressure by Arhatic Yoga meditation together with a vegetarian diet on the beneficial gut microbiome.
Conclusion
This pilot study demonstrates that Arhatic Yoga meditation practices combined with a vegetarian diet during a short intensive retreat resulted in enrichment of known health-promoting microbes. Such microbial consortia may be developed for potential health benefits and used as probiotics to improve the gastrointestinal and immune systems, as well as functions mediated by the gut-brain axis.
Trial registration
Study was submitted in https://clinicaltrials.gov/on28-02-2024. Retrospective registered.
Supplementary Information
The online version contains supplementary material available at 10.1186/s12906-025-04783-4.
Keywords: Arhatic yoga, Oral and gut microbiome, Beneficial microbes, Clinical trial, Gut-brain axis, Meditation
Introduction
The gut microbiome is a complex ecosystem of trillions of microorganisms residing in the gastrointestinal tract [1]. Rising number of studies have pointed out that the gut microbiome has a significant influence not only on gastro-intestinal health but on the development and progression of systemic diseases such as cardio-metabolic, auto-immune, and neuropsychiatric [2–6]. The stability of human gut microbiome varies with host genetics, age, lifestyle, and diet [7]. In addition, physical activity, exercise, and yoga changes the gut and oral microbial composition with possible benefits for the host [8–10].
The gut microbiome influences the maintenance of health and disease development and progression through the production of metabolites and signalling molecules which then enter systemic circulation and have an effect on the metabolic, immunologic, and homeostatic functions of different organs [11–13]. As such a balanced gut microbiome (eubiosis) facilitates the right composition of bacteria derived metabolites to maintain human health and prevents disease development and progression. On the contrary an imbalanced gut microbiome (dysbiosis) can lead to increased oxidative stress, inflammation, and gut-barrier permeability as well as metabolic dysfunction [14, 15]. This in turn, will have detrimental effects on the pathophysiology and subsequent development and progression of disease.
Given the above, it is not surprising that there has been a rising focus on the evaluation of therapies and interventions that promote gut eubiosis. Plant-based diet, supplementation with pre- and probiotics and gut faecal transplantation are well known to modulate the gut microbiome [16–18]. Additionally, few studies have demonstrated that active components of the plant secondary metabolites and/or plant extract improve lipid metabolism, enhance intestinal gut barrier function, inhibit fat accumulation, reduce inflammation, and regulate the abundance of gut microbiome, which ultimately improve the health state of the host [19–23]. Meditation practices, exercise, proper diet, and yoga are increasingly being incorporated as therapeutic interventions to improve mental and health disorders and have been suggested in several studies to have a beneficial effect on gut microbiota composition [9, 24–28]. However, the understanding of the role of meditation in gut and oral microbiome modulation is not well understood. A systematic review highlighted the importance of meditation in regulating the stress response and promoting the healthy gut-barrier function [25]. This review also recommended that it is necessary to explore the effects of meditation on gut microbiome and the functions in oral-gut axis. Moreover, several reports suggest that psychological stress may also affect the oral microbiome along with alteration in gut microbiota through oral-brain axis and oral-gut axis, respectively [29–31]. Direct link between gut homeostasis and stress-related disorders have also been reviewed recently [32, 33]. Upon stress, hypothalamus releases corticotropin-releasing factor (CRF) which disrupts the gastrointestinal system including oxidative damage to the colon, inflammation to the intestine, dysfunction intestinal barrier and triggers immune response [33–37]. Hence, it is intriguing to understand the role of Arhatic Yoga practices, which includes a vegetarian diet, in modulation of both oral and gut microbiome.
The present study was designed as a single-arm pilot scale to understand the temporal changes in both gut and oral microbiome of the practitioners at a meditation-cum-spiritual retreat in a controlled environment. Here, the study and its outcomes are reported according to Biofield Therapies: Reporting Evidence Guidelines (BiFi REGs) recommendations [38]. In brief, an Arhatic Yoga spiritual retreat was conducted for 9 days in Bovina, New York, USA. Arhatic Yoga is an advanced spiritual practice to enhance the physical, emotional, and mental aspects of the practitioner through an intensive daily regimen of physical and breathing exercises, meditations together with vegetarian diet, energetic purifications, self-awareness practices and spiritual studies. The energetic purifications are based on the hands-off modality of Pranic Healing, where the practitioners typically stand 50–60 cm away from the subjects [39]. This study provides a unique opportunity to test the hypotheses that (1) Arhatic Yoga practices will affect both oral and gut microbiome; (2) the oral and gut microbiome will shift dynamically in a short period; and (3) the overall shift resulting from the changes in the gut microbiome members will be associated with known benefits to health and well-being. To achieve this goal, we performed targeted 16S rRNA gene amplicon-based sequencing on both fecal and oral samples of twenty-four participants at three different timepoints of the retreat. This study aims to demonstrate that Pranic Healing and Arhatic Yoga practices combined with vegetarian diet promote the enrichment of healthy microbes. Findings from this study could be used as potential therapeutic interventions and preventions for improving and maintaining homeostasis and overall health.
Materials and methods
Recruitment of study participants and ethical statement
A subject must meet the following inclusion criteria to be eligible to participate in this study: (i) must provide written informed consent prior to initiation of any study procedures (ii) was able to understand and agreed to comply with planned study procedures (iii) agreed to the collection of specimens (saliva and fecal) before, during and after the study (iv) male or non-pregnant female greater than 18 years of age at time of enrolment and (v) must have a distinct Arhatic level (0–5 level) and performed meditation and MTH practices from once a week to more than 3 times a week prior to this retreat. A subject was excluded from the study if the following criteria were present: (i) concomitant disease that requires any medical treatment (ii) pregnancy, (iii) any antibiotic treatment the past two weeks (iv) pediatric population, (v) clinical apparent infectious disease. We calculated the sample size for this study as performed in human microbiome studies [40]. Adopted from the sample size calculation table from this study, we required 15 subjects to have 80% power at p < 0.05 significance level. Based on the above inclusion and exclusion criteria, 27 healthy registered practitioners in this retreat were recruited for this study and their informed consent were obtained. Age, gender, and basic vital signs such as height, weight, and body temperature were measured for each such practitioner (Supplementary Table S1). Ethical approval (IRB No: 22–08–521–1247) was obtained from Pranic Healing Research Institute before the start of the study. This study complies with the guidelines for biofield therapies called Biofield Therapies: Reporting Evidence Guidelines (BiFi REGs) which was supplemented with CONSORT 2010 [38, 41, 42].
Intensive spiritual retreat protocol
The spiritual retreat was held in a 84-acre meditation center in Bovina, New York for a duration of 9 days. All practitioners had undertaken formal training on Pranic Healing, Meditation on Twin Hearts, and higher meditation practices at least six months prior to the retreat [43]. Daily retreat practices lasted typically for 16–18 h with occasional short breaks. These practices included combinations of specifically designed physical and breathing exercises to improve the energetic states and stillness. Exercises were followed by Pranic Healing and self-awareness practices. Meditations included Meditation on Twin Hearts [43, 44], Arhatic Yoga meditations of Kundalini meditation, Arhatic Dhyan and Meditation on the Higher Soul [43]. The schedule of the retreat (Supplementary Table S2) and daily meal plan (Supplementary Table S3) are provided in supplementary. The participants followed an identical vegetarian diet, with no recent histories of smoking, alcohol intake and illicit drugs. There was open communication between all the participants before, during and after the retreat. As all the practitioners followed group practices in one location under the supervision of the senior instructors, separate assessment of the adherence of the practitioners to the protocol was not performed.
Sample collection, DNA extraction, amplification, and amplicon sequencing
Oral and fecal samples of 24 practitioners were collected at the start (Day0: T1), middle (Day3: T2) and end (Day9:T3) of the retreat in a sterile container and sent for DNA extraction and sequencing to Metagenom Bio Life Science Inc, Waterloo, Canada. Being a single-arm, time-stamped study, no control groups were present, however, the timepoints served as comparators. Participant’s information was only available to the logistic coordinator. Samples were therefore blinded for DNA sequencing. For analysis and interpretation participant metadata as presented in Supplementary Table S1 were used, where participant name remained blinded. Total genomic DNA from stool and saliva was extracted with the Sox DNA Isolation Kit (Metagenom Bio Inc., Cat. no. 18011_S0) according to the supplier’s recommendation. The DNA was further subjected to amplification of V4 region of the 16S rRNA gene with primer set (515FB: 5’-GTGYCAGCMGCCGCGGTAA-3’ and 806RB: 5’-GGACTACNVGGGTWTCTAAT-3’) [45]. The PCR was set in triplicates for each sample (25 μl each). Each reaction mixture contained 2.5 μl of 10 × standard Taq buffer, 0.5 μl of 10 mM dNTP, 0.25 μl of BSA (20 mg/ml), 5.0 μl of 1 μM forward primer, 5.0 μl of 1 μM reverse primer, 5.0 μl DNA, 0.2 μl of Taq DNA polymerase (5u/μl) and 6.55 μl of PCR water. The PCR conditions were as follows: initial denaturation at 95 °C for 5 min, followed by 35 cycles of 95 °C for 30 s, 30 °C for 30 s and 72 °C for 50 s and then extended at 72 °C for 10 min. The triplicate PCR products were pooled and resolved with 2% TAE agarose gel. Equimolar pool of amplicons was prepared, quantified using Qubit dsDNA HS Assay Kit (Thermo Fisher Scientific Inc.) and was sequenced with MiSeq Reagent Kit v2 (2 × 250 cycles).
16S rRNA gene sequence analysis and statistics
The raw sequences obtained after sequencing were subjected to quality checking using FastQC [46]. The pre-processing and analysis were performed using Divisive Amplicon Denoising Algorithm 2 (DADA2) package v1.6.0 [47]. Primers and low-quality bases were removed from the end of the reads using filter and Trim function of DADA2. Non-chimeric and error-free amplicon sequence variants (ASVs) were generated and subjected to taxonomic assignments using SILVA Database (silva_nr-99_v138.1_train_set.fa.gz) [48, 49]. Decontam package was used to remove contaminants from the datasets using prevalence-based method [50]. The rarefaction curve was generated using rarecurve function of vegan package [51]. Both alpha (which deals with the richness, evenness, or both) and beta diversity (which compare the species diversity in two different ecosystems) metrics were generated by Phyloseq v3.4.2 R package [52]. Differences in alpha diversity metrics (which deals with the richness, evenness, or both) were tested using pairwise Wilcoxon test. Non-metric multidimensional scaling (NMDS) was performed with Bray–Curtis's dissimilarity matrix to understand the difference in the microbial community composition between the sampling sites (oral and gut), while principal coordinate analysis (PCoA) was performed to assess the change in the microbiome profile of the participants with time and different practices. Pairwise permutational ANOVA (PERMANOVA) with adjusted p-value was performed using the Bray-Curtis dissimilarity matrix to assess the difference in beta diversity using pairwise.adonis function. DESeq2 [53] analysis was performed to determine the differentially enriched or depleted ASVs during the retreat using Wald test with an adjusted p-value filter of p < 0.01. The predicted metabolic function of the gut microbiome was performed using the phylogenetic investigation of communities by reconstruction of unobserved states (PICRUSt2) [54] followed by identification of statistically significant differentially abundant functional KEGG categories/metabolisms between participants with time using STAMP software [55] implemented with Welch’s t-test and p-values were adjusted by Bonferroni correction. The raw sequences were submitted to the NCBI under Bioproject number PRJNA1071264. No changes were made to the trial outcomes after the trial commenced.
Results
Alpha and beta diversity of gut and oral microbiome of the practitioners
Targeted 16S rRNA gene-based amplicon sequencing was performed to assess the change or modulation in both gut and oral microbiome profiles of the participants during the retreat. In total, 24 fecal samples and 11 saliva samples were finally considered for the downstream analysis which yielded ~ 3.7 and ~ 2.2 million raw reads, respectively. After quality filtering, ~ 3.04 and ~ 1.66 million reads from fecal and saliva samples were obtained, respectively. These reads resulted in ~ 132 ± 38 and 84 ± 17 ASVs per fecal and saliva samples, respectively. The rarefaction curves of all analyzed samples attained saturation or plateau, indicating that the sequencing depth was sufficient to capture the maximum microbial diversity (Supplementary Fig. S1). The results further revealed that the alpha diversity measures (Shannon and Simpson index) of the gut microbiome did not show significant (p > 0.05) differences over time (Fig. 1a). On the contrary, oral microbiome profile showed a significant (p < 0.05) difference in the species richness and evenness at the end of the retreat (Fig. 1b). However, gut microbiome was richer and more diverse or complex than oral microbiome (Supplementary Fig. S2). Moreover, non-metric multidimensional scaling (NMDS) uncovered the difference in the microbiome profiles of oral and gut microbiome (Fig. 2). PERMANOVA analysis (p < 0.05) further supported the difference in the oral and gut microbiome structure. It was interesting to note that the gut microbiome profile of the practitioners varied over time as depicted from the PCoA analysis which was further supported by pairwise PERMANOVA analysis (p < 0.05 for T1 and T2; p = 0.05 for T1 and T3; p > 0.05 for T2 and T3) (Fig. 3a). Conversely, such changes in the oral microbiome profile were not observed over time (pairwise PERMANOVA analysis: p > 0.05 for T1 and T2; p > 0.05 for T1 and T3; p > 0.05 for T2 and T3) (Fig. 3b).
Fig. 1.
Alpha diversity measures of the fecal and oral microbiome. Timepoint variations in the alpha diversity measures of (a) fecal and (b) saliva samples. Pairwise-Wilcoxon test was performed to assess the significant difference in the alpha diversity parameters over time
Fig. 2.
Beta-diversity plot depicts difference in fecal and oral samples. (a) Non-metric dimensional scaling (NMDS) based on a Bray–Curtis dissimilarity matrix (Stress = 0.15) on microbiome profile of fecal and oral samples. (b) Distance to centroid is represented in box plot. Each dot represents the sample from each participant
Fig. 3.
Changes in microbiome profile of fecal and oral samples over time. Principal coordinate analysis (PCoA) ordination plot based on a Bray–Curtis dissimilarity matrix of microbiome profile of fecal (a) and oral (b) samples with time
Changes in gut and oral microbial community structure of the practitioners
The gut and oral microbiome structure of the practitioners at T1 timepoint was predominated by Firmicutes (gut: 81.25 ± 16.67 and oral:76.72 ± 7.37) followed by Actinobacteriota (gut: 4.17 ± 3.85 and oral:14.7 ± 7.9), Bacteroidota (gut: 12.74 ± 16.27and oral: 4.73 ± 4.52), and Proteobacteria (gut: 1.01 ± 2.26 and oral: 2.59 ± 2.76) members (Supplementary Fig. S3). At the end of the retreat at T3 timepoint, a significant (Pairwise Wilcoxon text, p < 0.05) decrease in abundance of Bacteroidota (5.84 ± 8.39) members was observed in the gut, while a significant (Pairwise Wilcoxon text, p < 0.05) increase in relative abundance of Actinobacteriota (9.55 ± 10.04) members in the gut of the practitioners was observed. Additionally, several microbial genera showed a prominent shift in their abundance patterns over time. Among them, relative abundance of Ruminococcus torques group, Akkermansia, Pseudomonas, Romboutsia, Streptococcus, Subdoligranulum, and Ligilactobacillus increased over time in gut of the practitioners and categorized them under persistent responders (Fig. 4). While Blautia, Eubacterium halli group, Alistipes, Enterococcus, Clostridium sensu stricto 1, Bacteroides, and Anaerostipes showed reduction in the relative abundance of the gut of practitioners from T1 to T3 (Fig. 4). In case of oral microbiome, Abiotrophia and Porphyromonas were the persistent responders, whereas the abundance of Leptotrichia, Lachnoaerobaculum, Leuconostoc, Oribacterium, and Solobacterium decreased from T1 to T3 (Fig. 5). Interestingly, there were microbes which showed transient response [increased in abundance was observed till T2, thereafter declined (T3)] in their abundance pattern during the retreat in gut (Agathobacter, Bifidobacteria, Collinsella, Coprococcus, Dorea, Monoglobus, Fusicatenibacter, Ruminococcus, Anaerostipes, and Bacteroides) and oral (Granulicatella, Gemella, Pseudomonas, Rothia, Streptococcus, and Veillonella) samples of the practitioners.
Fig. 4.
Line graph representing the change in average abundance of major bacterial taxa (top 25) with time in fecal samples
Fig. 5.
Line graph representing the change in average abundance of major bacterial taxa (top 25) with time in oral samples
The specific alterations in gut microbiome associated with practice during the retreat over time were further resolved based on DESeq2 based analysis. Several differentially abundant ASVs were identified which showed significant (p < 0.05) changes in their abundance with time (T1 vs T3) (Fig. 6). Certain ASVs associated with Erysipelotrichiaceae UCG-003 Eubacterium halli group, Blautia, Faecalibacterium, Fusicatenibacter, Ruminococcus torques group, Akkermansia, Bifidobacterium, Pseudomonas, Rombutsia, Streptococcus, Subdoligranulum, Turicibacter, Ligilactobacillus, Alistipes, Enterococcus, Clostridium sensu stricto 1, Bacteroides, and Anaerostipes showed prominent shift in their abundance at the end of the retreat (T1 vs T3), indicating the Arhatic Yoga meditation practices together with vegetarian diet had an impact on the modulation of certain groups of microbes to promote good health (Fig. 6). In order to assess the influence of age and gender in the gut microbiome changes, the participants were classified into three age categories (Category1: 30–45 years; Category2: 46–60 years; Category3: 61–75 years), two genders (male and female). Pairwise PERMANOVA comparisons between the categories and between the genders were not significantly different for their microbiome composition (Supplementary Table S4 and Table S5).
Fig. 6.
DESeq2 based identification of major microbial ASVs (p < 0.05) which are differentially abundant between timepoint T1 and T3 in fecal samples
Predictive metabolic function of the gut microbes
The predicted functional pathways of the gut microbiome were determined through PICRUSt2 analysis. The results revealed that predicted functional KEGG categories/metabolisms showed an enrichment of various pathways such as cysteine and methionine metabolism, selenocompound metabolism, glycine, serine, and threonine metabolisms, sulfur metabolism, nicotinate and nicotinamide metabolism, and glycerophospholipid metabolism at the end of the retreat (T3 timepoint) (Fig. 7). However, folate biosynthesis, drug metabolism, pentose and glucuronate interconversions, and riboflavin metabolism were relatively reduced at the end of the retreat.
Fig. 7.
Differentially abundant KEGG derived metabolic pathways of fecal samples between. T1 and T3 timepoints
Changes in the gut microbiome profile based on the Arhatic Yoga level, Meditation on Twin hearts (MTH), and meditation practices of the practitioners during retreat
Each practitioner who participated in the retreat already had a distinct Arhatic level (0–5 level) and performed meditation and MTH practices from once a week to more than 3 times a week. We further tried to understand the changes in gut microbiome profile of these participants during the retreat where they were exposed to the same environment, training, practices, and vegetarian food. The results revealed the slight convergence of the microbiome of the practitioners with higher Arhatic level (3 and above) at the end of the retreat (Supplementary Fig. S4a). Similarly, microbial profiles of frequent practitioners (3 or more times a week) of MTH and meditation converged more than non-frequent practitioners (Supplementary Fig. S4b and Fig. S4c). However, these results were not statistically significant (p > 0.05) as confirmed by PERMANOVA analysis. Furthermore, we identified several differentially abundant ASVs (p < 0.05) which were associated with higher Arhatic level at T1 and T3 timepoints (Fig. 8). ASVs such as Erysipelotrichiaceae UCG-003 Eubacterium halli group, Blautia, Faecalibacterium, Fusicatenibacter, Ruminococcus torques group, Akkermansia, Bifidobacterium, Pseudomonas, Rombutsia, Streptococcus, Subdoligranulum, Turicibacter, Ligilactobacillus, Alistipes, Enterococcus, Clostridium sensu stricto 1, Bacteroides, and Anaerostipes predominated in the practitioners with higher Arhatic level at T3 timepoint.
Fig. 8.
DESeq2 based identification of major bacterial ASVs (p < 0.05) which are differentially abundant between practitioners with different Arhatic levels at timepoint T1 (a) and T3 (b) in fecal samples
Discussion
Yoga and meditation practices, physical activities, and exercises have been reported to improve gastrointestinal disorders and mental health [30, 56–60]. Arhatic Yoga is a global non-sectarian spiritual practice which cultivates holistic development of the physical, emotional, and mental aspects [39, 43]. The impact of meditation and vegetarian diet on the modulation of gut and oral microbiome is not well understood. This study is the first of its kind in two respects. Firstly, to assess the impact of intensive meditation practices on the modulation of microbiomes in a controlled environment, where all the participants followed the same lifestyle and practices. Secondly, to demonstrate the associations of meditations in a short span of 9 days on the oral and gut microbiome leading to better understanding of its effects. This pilot study demonstrated that Arhatic Yoga meditation together with a vegetarian diet enriched the health-benefiting microbes both in the gut and oral environments. Hence, meditation could be incorporated in our day-to-day life to modulate our oral and gut microbiome for health benefits.
Our findings suggested that the oral microbiome had a more pronounced effect on alpha diversity parameters than gut microbiome profile at the end of the retreat. This might be due to the microbes that were acquired during the retreat practices from the combination of lifestyle and diet. Although there were no overall changes in beta-diversity in the case of oral microbiome, several health beneficial microbes were enriched in the oral microbiome structure during the retreat. Most noteworthy are Corynebacterium, Rothia, and Neisseria, which are known for the nitrate-nitrite-nitric oxide pathway that plays a significant role in providing oral microbiome-mediated nitric oxide signaling molecules for cardiovascular or metabolic health [61, 62].
Our results showed that the gut microbiota composition of the participants changed in the short-term span, indicating that Arhatic Yoga meditation together with a vegetarian diet had substantial influence on gut microbiota composition. The effect of the changes in the composition of the microbiota on health and well-being can be supported by the predicted enrichment of certain microbial metabolic pathways such as the amino acid metabolism of selonocompound, cysteine, methionine, glycine, serine, and threonine. Similarly, the predicted enrichment of nicotinate and nicotinamide metabolism, glycerophospholipid metabolism and chlorocyclohexane and chlorobenzene degradation indicated potential detoxification benefits. Nicotinate and nicotinamide are precursors of the coenzymes nicotinamide-adenine dinucleotide (NAD +) and nicotinamide-adenine dinucleotide phosphate (NADP +) which in their reduced form, NADH and NADPH respectively, are important co-factors in many redox reactions, including the chemical modification of DNA, RNA, and certain proteins [63, 64]. Methionine plays a role in the activation of certain antioxidant enzymes and biosynthesis of glutathione, which is key in counteracting oxidative stress [65]. Physical activities have previously shown the changes in amino acid metabolism, which might play a role in redox balance, oxidative stress, and immune function [66–68]. Glycerophospholipids are critical components of neuronal membranes and myelin, and principal regulators of synaptic function and might play crucial role in gut-brain axis [69].
Furthermore, we identified several bacterial members that differed significantly with time. Increased abundance of Erysipelotrichaeceae UCG-003, Ruminococcus torques group, Subdoligranulum, Ruminococcus, Fecalibacterium, Roseburia, Akkermansia, Romboutsia, and Bifidobacterium in the present study is in line with previous studies associated with gut microbiome profile of high-intensity competitive training of athletes or body builders, marathon runners, and moderate physical exercises or training along with vegan meditation and mindfulness cognitive therapy [8, 26, 70–78]. Ruminococcus torques group; Subdoligranulum; Erysipelotrichaeceae UCG-003, Ruminococcus, Fecalibacterium, and Roseburia are the SCFAs (short-chain fatty acid) producing microbes and play significant roles in the immune modulation as well as in gut-brain axis [79–81]. SCFAs are known to play significant roles locally in improving gut health. For example, it maintains gut barrier integrity and protects from intestinal inflammation [80, 82]. SCFAs are also recognized as a key play in gut-brain axis and influence gut–brain function through endocrine, immune, vagal, and humoral pathways [82]. Hence, increased abundance of the above-mentioned SCFAs producing genera in the present study might play a significant role in modulating the gut-brain axis. Akkermansia species participate in the gut-barrier functions and are linked with a healthier metabolic status of the human body [83]. Ligilactobacillus, Romboutsia and Turicibacter have been reported in other non-meditation studies to have health-benefiting effects. Ligilactobacillus species are known to protect intestinal barrier [84] and recently, Ligilactobacillus salivarius was used as probiotic which improved the body growth and antioxidation capacity via microbiota-gut-brain axis in non-human model [85]. It has been reported that Ligilactobacillus salivarius also modulates the behaviour in non-human autistic model through microbiota-gut-brain axis [86]. Romboutsia species are involved in amino acid metabolism which might be positively associated with the gut-brain axis [87, 88]. For instance, there have been several reports where abundance of Lachnospiraceae, Romboutsia, and Faecalibacterium genera reduced in patients with anxiety, depression, and autism which influenced neural, immune, and endocrine pathways [87, 89–91]. Increased abundance of these genera in the present study further supported that Arhatic Yoga meditation with vegetarian diet improved the gut microbiome composition by enriching the beneficial microbes which could be involved in improving the gut-brain communications and mental health. Interestingly, the Meditation on Twin Hearts that was practiced daily during this study period produces significant changes on the brain qualitative electroencephalogram, particularly increase in P300 response times and gamma waves [44]. Hence, Meditation on Twin Hearts could have additionally contributed to the gut-brain axis in a positive manner.
As such, these meditation practices could be implemented into the regular lifestyles to improve gut microbiota composition. This in turn, promotes good health by reduction in inflammation, and gut-barrier permeability along with improvement of gut-brain function. Our data further suggests that frequent practitioners of Meditation of Twin Hearts and higher Arhatic meditation practices showed the convergence of microbiome profile with increased abundance of health-promoting microbes which results from a controlled practices during the retreat. Whereas practitioners with the lower arhatic levels and infrequent meditation practices also showed shift in their gut profile and tend towards the convergence not as evident in case of higher arhatic level practitioners. Further investigations are required to delineate the effect of diet and meditation practices on such changes as multiple confounding variables are associated with such observations.
Overall, our study suggested that Arhatic Yoga practices together with vegetarian diet showed prominent effects on both the gut microbiome and the oral microbiome in a noticeably short span of time. However, the study has certain limitations such as a single-arm study with small size of datasets and lack of metabolite profiles of practitioners. Future studies may build from this work to deconvolute the effect of diet and meditation practices from the overall responses as well as long-term effect of these on the well-being of the participants through multi-omics approaches. Future studies will be designed with multiple controls to delineate the diet and meditation effect on the gut microbiome. The microbial metabolites linked with the regulation of immune response and neuromodulation will also help us to better understand the gut-brain axis. However, metatranscriptomics/metagenomics would further help in identifying the differences in expression profiles of the microbiome over time in response to these practices.
Conclusion
This study demonstrated that Arhatic Yoga meditation together with a vegetarian diet during a short intensive retreat resulted in increased alpha diversity of oral microbiome and beta diversity of the gut microbiome. Known health-promoting microbes were associated with these rapid changes. Such microbial consortia may be developed and used as probiotics to accelerate the benefits of both gut and oral microbiome functions.
Supplementary Information
Acknowledgements
We thank Susan Rotenberg PhD and Praveen Chandrasekharan MD for their critical comments on the manuscript. Cynthia Holland for logistics assistance. The Center for Pranic Healing USA and Pranic Healing Research Institute PHRI for providing logistics support for the study.
Authors’ contributions
The study was designed by SS and GM. MC, VD, SS, and GM were responsible for coordination and implementation of the study protocol. MC, VD, and GM were responsible for sample collection and transport. MDJL, JC, and TCC were involved in study design, sampling strategy, DNA extraction, DNA sequencing and quality assurance. AG provided support on sequencing data analysis. AG with help of SS analyse the datasets. AG and SS involved in initial draft preparation. AG, SS, VR, GM, and MC, were involved in finalizing the final draft. All authors read and approved the final manuscript.
Funding
This research was funded by Center for Pranic Healing, USA and Pranic Healing Research Institute PHRI, USA.
Data availability
Data is provided within the manuscript.
Declarations
Ethics approval and consent to participate
Ethical approval (IRB No: 22–08-521–1247) was obtained from Pranic Healing Research Institute before the start of the study. Informed consents were obtained from the participants.
Consent for publication
All authors have provided their consent.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Sanjay Swarup and Abhishek Gupta contributed equally to this work.
References
- 1.Hou K, Wu ZX, Chen XY, Wang JQ, Zhang D, Xiao C, Zhu D, Koya JB, Wei L, Li J, Chen ZS. Microbiota in health and diseases. Signal Transduct Target Ther. 2022;7(1):135. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Aziz Q, Doré J, Emmanuel A, Guarner F, Quigley EM. Gut microbiota and gastrointestinal health: current concepts and future directions. Neurogastroenterol Motil. 2013;25(1):4–15. [DOI] [PubMed] [Google Scholar]
- 3.Tilg H, Moschen AR. Microbiota and diabetes: an evolving relationship. Gut. 2014;63(9):1513–21. [DOI] [PubMed] [Google Scholar]
- 4.Xu H, Wang X, Feng W, Liu Q, Zhou S, Liu Q, Cai L. The gut microbiota and its interactions with cardiovascular disease. Microb Biotechnol. 2020;13(3):637–56. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Zhang X, Zhao LD, Li H. The gut microbiota: emerging evidence in autoimmune diseases. Trends Mol Med. 2020;26(9):862–73. [DOI] [PubMed] [Google Scholar]
- 6.Queiroz SA, Ton AM, Pereira T, Campagnaro BP, Martinelli L, Picos A, Campos-Toimil M, Vasquez EC. The gut microbiota-brain axis: a new frontier on neuropsychiatric disorders. Front Psych. 2022;13: 872594. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Moitinho-Silva L, Wegener M, May S, Schrinner F, Akhtar A, Boysen TJ, Schaeffer E, Hansen C, Schmidt T, Rühlemann MC, Hübenthal M. Short-term physical exercise impacts on the human holobiont obtained by a randomised intervention study. BMC Microbiol. 2021;21(1):162. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Monda V, Villano I, Messina A, Valenzano A, Esposito T, Moscatelli F, et al. Exercise modifies the gut microbiota with positive health effects. Oxid Med Cell Longev. 2017;2017(1):1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Dalton A, Mermier C, Zuhl M. Exercise influence on the microbiome–gut–brain axis. Gut microbes. 2019;10(5):555–68. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Bryan NS, Burleigh MC, Easton C. The oral microbiome, nitric oxide and exercise performance. Nitric Oxide. 2022;125:23–30. [DOI] [PubMed] [Google Scholar]
- 11.Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nat Rev Immunol. 2016;16(6):341–52. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Schroeder BO, Bäckhed F. Signals from the gut microbiota to distant organs in physiology and disease. Nat Med. 2016;22(10):1079–89. [DOI] [PubMed] [Google Scholar]
- 13.Silva YP, Bernardi A, Frozza RL. The role of short-chain fatty acids from gut microbiota in gut-brain communication. Front Endocrinol. 2020;11:25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Genua F, Raghunathan V, Jenab M, Gallagher WM, Hughes DJ. The role of gut barrier dysfunction and microbiome dysbiosis in colorectal cancer development. Front Oncol. 2021;11: 626349. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Wang H, Wang G, Banerjee N, Liang Y, Du X, Boor PJ, Hoffman KL, Khan MF. Aberrant gut microbiome contributes to intestinal oxidative stress, barrier dysfunction, inflammation and systemic autoimmune responses in MRL/lpr mice. Front Immunol. 2021;12: 651191. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Adithya KK, Rajeev R, Selvin J, Seghal KG. Dietary influence on the dynamics of the human gut microbiome: Prospective implications in interventional therapies. ACS Food Science & Technology. 2021;1(5):717–36. [Google Scholar]
- 17.Hitch TC, Hall LJ, Walsh SK, Leventhal GE, Slack E, de Wouters T, Walter J, Clavel T. Microbiome-based interventions to modulate gut ecology and the immune system. Mucosal Immunol. 2022;15(6):1095–113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Liu Y, Wang J, Wu C. Modulation of gut microbiota and immune system by probiotics, pre-biotics, and post-biotics. Front Nutr. 2022;8: 634897. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Li D, Tang W, Wang Y, Gao Q, Zhang H, Zhang Y, Zhao H. An overview of traditional Chinese medicine affecting gut microbiota in obesity. Front Endocrinol. 2023;14:1149751. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Xiao S, Zhang Z, Chen M, Zou J, Jiang S, Qian D, Duan J. Xiexin Tang ameliorates dyslipidemia in high-fat diet-induced obese rats via elevating gut microbiota-derived short chain fatty acids production and adjusting energy metabolism. J Ethnopharmacol. 2019;241: 112032. [DOI] [PubMed] [Google Scholar]
- 21.Zhang R, Gao X, Bai H, Ning K. Traditional Chinese medicine and gut microbiome: their respective and concert effects on healthcare. Front Pharmacol. 2020;11:538. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Wang K, Ma J, Li Y, Han Q, Yin Z, Zhou M, Xia S. Effects of essential oil extracted from Artemisia argyi leaf on lipid metabolism and gut microbiota in high-fat diet-fed mice. Front Nutr. 2022;9:1024722. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Vignesh A, Amal TC, Selvakumar S, Vasanth K. Unraveling the role of medicinal plants and Gut microbiota in colon cancer: towards microbiota-based strategies for prevention and treatment. Health Sci Rev. 2023;9:100115.
- 24.Venditti S, Verdone L, Reale A, Vetriani V, Caserta M, Zampieri M. Molecules of silence: Effects of meditation on gene expression and epigenetics. Front Psychol. 2020;11:1767. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Househam AM, Peterson CT, Mills PJ, Chopra D. The effects of stress and meditation on the immune system, human microbiota, and epigenetics. Adv Mind Body Med. 2017;31(4):10–25. [PubMed] [Google Scholar]
- 26.Clauss M, Gérard P, Mosca A, Leclerc M. Interplay between exercise and gut microbiome in the context of human health and performance. Front Nutr. 2021;8: 637010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Raman M, Vishnubhotla R, Ramay HR, Gonçalves MC, Shin AS, Pawale D, Subramaniam B, Sadhasivam S. Isha yoga practices, vegan diet, and participation in Samyama meditation retreat: impact on the gut microbiome & metabolome–a non-randomized trial. BMC Complementary Medicine and Therapies. 2023;23(1):1–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Danhauer SC, Addington EL, Sohl SJ, Chaoul A, Cohen L. Review of yoga therapy during cancer treatment. Support Care Cancer. 2017;25:1357–72. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Duran-Pinedo AE, Solbiati J, Frias-Lopez J. The effect of the stress hormone cortisol on the metatranscriptome of the oral microbiome. npj Biofilms and Microbiomes. 2018;4(1):25. [DOI] [PMC free article] [PubMed]
- 30.Paudel D, Kuramitsu Y, Uehara O, Morikawa T, Yoshida K, Giri S, Islam ST, Kitagawa T, Kondo T, Sasaki K, Matsuoka H. Proteomic and microbiota analyses of the oral cavity during psychological stress. PLoS ONE. 2022;17(5): e0268155. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Paudel D, Uehara O, Giri S, Yoshida K, Morikawa T, Kitagawa T, Matsuoka H, Miura H, Toyofuku A, Kuramitsu Y, Ohta T. Effect of psychological stress on the oral-gut microbiota and the potential oral-gut-brain axis. Japanese Dental Science Review. 2022;58:365–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Chang L. The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome. Gastroenterology. 2022;140(3):761–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Zhang H, Wang Z, Wang G, Song X, Qian Y, Liao Z, Xia Y. Understanding the connection between gut homeostasis and psychological stress. J Nutr. 2023;153(4):924–39. [DOI] [PubMed] [Google Scholar]
- 34.Colón AL, Madrigal JL, Menchén LA, Moro MA, Lizasoain I, Lorenzo P, Leza JC. Stress increases susceptibility to oxidative/nitrosative mucosal damage in an experimental model of colitis in rats. Dig Dis Sci. 2004;49:1713–21. [DOI] [PubMed] [Google Scholar]
- 35.Barreau F, Cartier C, Leveque M, Ferrier L, Moriez R, Laroute V, Bueno L. Pathways involved in gut mucosal barrier dysfunction induced in adult rats by maternal deprivation: corticotrophin-releasing factor and nerve growth factor interplay. J Physiol. 2007;580(1):347–56. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Ge L, Liu S, Li S, Yang J, Hu G, Xu C, Song W. Psychological stress in inflammatory bowel disease: Psychoneuroimmunological insights into bidirectional gut–brain communications. Front Immunol. 2022;13:1016578. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Warren A, Nyavor Y, Beguelin A, Frame LA. Dangers of the chronic stress response in the context of the microbiota-gut-immune-brain axis and mental health: a narrative review. Front Immunol. 2024;15:1365871. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Hammerschlag R, Sprengel M, Baldwin AL. Biofield therapies: guidelines for reporting clinical trials. Glob Adv Int Med Health. 2024;13:1–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Sui CK. Miracles through pranic healing: Practical manual on energy healing. Energetic Solutions, Inc. 2004.
- 40.La Rosa PS, Brooks JP, Deych E, Boone EL, Edwards DJ, Wang Q, Sodergren E, Weinstock G, Shannon WD. Hypothesis testing and power calculations for taxonomic-based human microbiome data. PLoS ONE. 2012;7(12): e52078. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. J Pharmacol Pharmacother. 2010;1(2):100–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (Chinese version). Journal of Chinese Integrative Medicine. 2010;8(8):701–41. [Google Scholar]
- 43.Sui MC. The Origin of Modern Pranic Healing and Arhatic Yoga. Institute for Inner Studies Publishing Foundation Inc. 2006.
- 44.Tarrant JM, Raines N, Blinne WR. The effects of meditation on twin hearts on P300 values: A repeated measures comparison of nonmeditators and the experienced. Integrative Medicine: A Clinician’s Journal. 2019;18(2):36. [PMC free article] [PubMed] [Google Scholar]
- 45.Walters W, Hyde ER, Berg-Lyons D, Ackermann G, Humphrey G, Parada A, Gilbert JA, Jansson JK, Caporaso JG, Fuhrman JA, Apprill A. Improved bacterial 16S rRNA gene (V4 and V4–5) and fungal internal transcribed spacer marker gene primers for microbial community surveys. Msystems. 2016;1(1):e00009–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Andrews S. FastQC: a quality control tool for high throughput sequence data. 2010.
- 47.Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJ, Holmes SP. DADA2: High-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13(7):581–3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, Peplies J, Glöckner FO. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2012;41(D1):D590–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Yilmaz P, Parfrey LW, Yarza P, Gerken J, Pruesse E, Quast C, Schweer T, Peplies J, Ludwig W, Glöckner FO. The SILVA and “all-species living tree project (LTP)” taxonomic frameworks. Nucleic Acids Res. 2014;42(D1):D643–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Davis NM, Proctor DM, Holmes SP, Relman DA, Callahan BJ. Simple statistical identification and removal of contaminant sequences in marker-gene and metagenomics data. Microbiome. 2018;6:1–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Oksanen J, Blanchet FG, Kindt R, Legendre P, Minchin PR, O’hara RB, et al. Package ‘vegan’. Community ecology package, version. 2013;2(9):1–295.
- 52.McMurdie PJ, Holmes S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS ONE. 2013;8(4):e61217. [DOI] [PMC free article] [PubMed]
- 53.Love M, Anders S, Huber W. Differential analysis of count data–the DESeq2 package. Genome Biol. 2014;15(550):10–186. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Douglas GM, Maffei VJ, Zaneveld JR, Yurgel SN, Brown JR, Taylor CM, Huttenhower C, Langille MG. PICRUSt2 for prediction of metagenome functions. Nat Biotechnol. 2020;38(6):685–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Parks DH, Tyson GW, Hugenholtz P, Beiko RG. STAMP: statistical analysis of taxonomic and functional profiles. Bioinformatics. 2014;30(21):3123–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Büssing A, Michalsen A, Khalsa SB, Telles S, Sherman KJ. Effects of yoga on mental and physical health: a short summary of reviews. Evid Based Complement Alternat Med. 2012;2012:1–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Marchand WR. Mindfulness-based stress reduction, mindfulness-based cognitive therapy, and Zen meditation for depression, anxiety, pain, and psychological distress. J Psychiatric Practice®. 2012;18(4):233–52. [DOI] [PubMed]
- 58.Abbott R, Lavretsky H. Tai Chi and Qigong for the treatment and prevention of mental disorders. The psychiatric clinics of North America. 201336(1):109. [DOI] [PMC free article] [PubMed]
- 59.Bower JE, Crosswell AD, Stanton AL, Crespi CM, Winston D, Arevalo J, Ma J, Cole SW, Ganz PA. Mindfulness meditation for younger breast cancer survivors: a randomized controlled trial. Cancer. 2015;121(8):1231–40. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Chételat G, Lutz A, Arenaza-Urquijo E, Collette F, Klimecki O, Marchant N. Why could meditation practice help promote mental health and well-being in aging? Alzheimer’s research & therapy. 2018;10(1):1–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Vanhatalo A, Blackwell JR, L’Heureux JE, Williams DW, Smith A, van der Giezen M, Winyard PG, Kelly J, Jones AM. Nitrate-responsive oral microbiome modulates nitric oxide homeostasis and blood pressure in humans. Free Radical Biol Med. 2018;124:21–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Rosier BT, Buetas E, Moya-Gonzalvez EM, Artacho A, Mira A. Nitrate as a potential prebiotic for the oral microbiome. Sci Rep. 2020;10(1):12895. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Magni G, Amici A, Emanuelli M, Raffaelli N, Ruggieri S. Enzymology of NAD+ synthesis. Advances in Enzymology and Related Areas of Molecular Biology: Mechanism of Enzyme Action, Part A. 1999;73:135–82. [DOI] [PubMed] [Google Scholar]
- 64.Xie N, Zhang L, Gao W, Huang C, Huber PE, Zhou X, Li C, Shen G, Zou B. NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential. Signal Transduct Target Ther. 2020;5(1):227. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Martínez Y, Li X, Liu G, Bin P, Yan W, Más D, Valdivié M, Hu CA, Ren W, Yin Y. The role of methionine on metabolism, oxidative stress, and diseases. Amino Acids. 2017;49:2091–8. [DOI] [PubMed] [Google Scholar]
- 66.Sharifi-Rad M, Anil Kumar NV, Zucca P, Varoni EM, Dini L, Panzarini E, Rajkovic J, Tsouh Fokou PV, Azzini E, Peluso I, Prakash MA. Lifestyle, oxidative stress, and antioxidants: Back and forth in the pathophysiology of chronic diseases. Front Physiol. 2020;11:694. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Lee JY, Paik IY, Kim JY. Voluntary exercise reverses immune aging induced by oxidative stress in aging mice. Exp Gerontol. 2019;115:148–54. [DOI] [PubMed] [Google Scholar]
- 68.Posey EA, Bazer FW, Wu G. Amino acids and their metabolites for improving human exercising performance. Amino Acids in Nutrition and Health: Amino Acids in Gene Expression, Metabolic Regulation, and Exercising Performance. 2021;1332:151–66. [DOI] [PubMed]
- 69.Zheng P, Wu J, Zhang H, Perry SW, Yin B, Tan X, Chai T, Liang W, Huang Y, Li Y, Duan J. The gut microbiome modulates gut–brain axis glycerophospholipid metabolism in a region-specific manner in a nonhuman primate model of depression. Mol Psychiatry. 2021;26(6):2380–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Bielik V, Hric I, Ugrayová S, Kubáňová L, Putala M, Grznár Ľ, Penesová A, Havranová A, Šardzíková S, Grendar M, Baranovičová E. Effect of High-intensity Training and Probiotics on Gut Microbiota Diversity in Competitive Swimmers: Randomized Controlled Trial. Sports medicine-open. 2022;8(1):1–1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Barton W, Cronin O, Garcia-Perez I, Whiston R, Holmes E, Woods T, Molloy CB, Molloy MG, Shanahan F, Cotter PD, O’Sullivan O. The effects of sustained fitness improvement on the gut microbiome: a longitudinal, repeated measures case-study approach. Translational Sports Medicine. 2021;4(2):174–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Mohr AE, Jäger R, Carpenter KC, Kerksick CM, Purpura M, Townsend JR, West NP, Black K, Gleeson M, Pyne DB, Wells SD. The athletic gut microbiota. J Int Soc Sports Nutr. 2020;17(1):1–33. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Sato M, Suzuki Y. Alterations in intestinal microbiota in ultramarathon runners. Sci Rep. 2022;12(1):6984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Scheiman J, Luber JM, Chavkin TA, MacDonald T, Tung A, Pham LD, Wibowo MC, Wurth RC, Punthambaker S, Tierney BT, Yang Z. Meta-omics analysis of elite athletes identifies a performance-enhancing microbe that functions via lactate metabolism. Nat Med. 2019;25(7):1104–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Jang LG, Choi G, Kim SW, Kim BY, Lee S, Park H. The combination of sport and sport-specific diet is associated with characteristics of gut microbiota: an observational study. J Int Soc Sports Nutr. 2019;16(1):21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Bonomini-Gnutzmann R, Plaza-Díaz J, Jorquera-Aguilera C, Rodríguez-Rodríguez A, Rodríguez-Rodríguez F. Effect of intensity and duration of exercise on gut microbiota in humans: A systematic review. Int J Environ Res Public Health. 2022;19(15):9518. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Wang Z, Liu S, Xu X, Xiao Y, Yang M, Zhao X, Jin C, Hu F, Yang S, Tang B, Song C. Gut microbiota associated with effectiveness and responsiveness to mindfulness-based cognitive therapy in improving trait anxiety. Front Cell Infect Microbiol. 2022;12: 719829. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Jia W, Zhen J, Liu A, Yuan J, Wu X, Zhao P, et al. Long-term vegan meditation improved human gut microbiota. Evid Based Complement Alternat Med. 2020;2020:1–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Nogal A, Valdes AM, Menni C. The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health. Gut microbes. 2021;13(1):1897212. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.O’Riordan KJ, Collins MK, Moloney GM, Knox EG, Aburto MR, Fülling C, Morley SJ, Clarke G, Schellekens H, Cryan JF. Short chain fatty acids: Microbial metabolites for gut-brain axis signalling. Mol Cell Endocrinol. 2022;546: 111572. [DOI] [PubMed] [Google Scholar]
- 81.Sittipo P, Choi J, Lee S, Lee YK. The function of gut microbiota in immune-related neurological disorders: A review. J Neuroinflammation. 2022;19(1):1–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Dalile B, Van Oudenhove L, Vervliet B, Verbeke K. The role of short-chain fatty acids in microbiota–gut–brain communication. Nat Rev Gastroenterol Hepatol. 2019;16(8):461–78. [DOI] [PubMed] [Google Scholar]
- 83.Dao MC, Everard A, Aron-Wisnewsky J, Sokolovska N, Prifti E, Verger EO, Kayser BD, Levenez F, Chilloux J, Hoyles L, Dumas ME. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut. 2016Mar 1;65(3):426–36. [DOI] [PubMed] [Google Scholar]
- 84.Yao M, Lu Y, Zhang T, Xie J, Han S, Zhang S, Fei Y, Ling Z, Wu J, Hu Y, Ji S. Improved functionality of Ligilactobacillus salivarius Li01 in alleviating colonic inflammation by layer-by-layer microencapsulation. npj Biofilm Microbiomes. 2021;7(1):58. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Yang J, Wang J, Liu Z, Chen J, Jiang J, Zhao M, Gong D. Ligilactobacillus Salivarius improve body growth and anti-oxidation capacity of broiler chickens via regulation of the microbiota-gut-brain axis. BMC Microbiol. 2023;23(1):395. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Pochakom A, Mu C, Rho JM, Tompkins TA, Mayengbam S, Shearer J. Selective probiotic treatment positively modulates the microbiota–gut–brain Axis in the BTBR mouse model of autism. Brain Sci. 2022;12(6):781. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Yap CX, Henders AK, Alvares GA, Wood DL, Krause L, Tyson GW, Restuadi R, Wallace L, McLaren T, Hansell NK, Cleary D. Autism-related dietary preferences mediate autism-gut microbiome associations. Cell. 2021;184(24):5916–31. [DOI] [PubMed] [Google Scholar]
- 88.Vaher K, Bogaert D, Richardson H, Boardman JP. Microbiome-gut-brain axis in brain development, cognition and behavior during infancy and early childhood. Dev Rev. 2022;66: 101038. [Google Scholar]
- 89.Huang TT, Lai JB, Du YL, Xu Y, Ruan LM, Hu SH. Current understanding of gut microbiota in mood disorders: an update of human studies. Front Genet. 2019;10:98. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Verma H, Phian S, Lakra P, Kaur J, Subudhi S, Lal R, Rawat CD. Human gut microbiota and mental health: advancements and challenges in microbe-based therapeutic interventions. Indian journal of microbiology. 2020;60:405–19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Du Y, Gao XR, Peng L, Ge JF. Crosstalk between the microbiota-gut-brain axis and depression. Heliyon. 2020;6(6). [DOI] [PMC free article] [PubMed]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Data is provided within the manuscript.